Development, characterization and toxicological evaluations of phospholipids complexes of curcumin for effective drug delivery in cancer chemotherapy

References

• Aggarwal BB, Kumar A, Bharti AC. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363–98
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Sundaram C, Malani N, Ichikawa H. (2007). Curcumin: the Indian solid gold. Adv Exp Med Biol 595:1–75
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Sung B. (2009). Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30:85–94
   PubMed Web of Science ®Google Scholar
• Anitha A, Maya S, Deepa N, et al. (2012). Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery. J Biomater Sci Polym Ed 23:1381–400
   Google Scholar
• Araujo CC, Leon LL. (2001). Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 96:723–8
   PubMed Web of Science ®Google Scholar
• Baglole KN, Boland PG, Wagner BD. (2005). Fluorescence enhancement of curcumin upon inclusion into parent and modified cyclodextrins. J Photochem Photobiol A 173:230–7
   Web of Science ®Google Scholar
• Balogun E, Hoque M, Gong P, et al. (2003). Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371:887–95
   PubMed Web of Science ®Google Scholar
• Byrne JD, Betancourt T, Brannon-Peppas L. (2008). Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60:1615–26
   PubMed Web of Science ®Google Scholar
• Camacho-Barquero L, Villegas I, Sánchez-Calvo JM, et al. (2007). Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 7:333–42
   PubMed Web of Science ®Google Scholar
• Chen Y, Wu Q, Zhang Z, et al. (2012). Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 17:5972–87
   PubMed Web of Science ®Google Scholar
• Ciochina AD, Bredeţean O, Dimitriu DC, Iacob G. (2009). [Considerations on in vitro and in vivo magnetic nanoparticles hemocompatibility testing]. Rev Med Chir Soc Med Nat Iasi 113:279–85
   PubMedGoogle Scholar
• Conti M, Malandrino S, Magistretti MJ. (1992). Protective activity of silipide on liver damage in rodents. Jpn J Pharmacol 60:315–21
   PubMedGoogle Scholar
• Development of ECa. (1996). OECD guidelines for the testing of chemicals, Test guideline 423, Acute oral toxicity–acute toxic class method. Paris: OECD
   Google Scholar
• Dhule SS, Penfornis P, Frazier T, et al. (2012). Curcumin-loaded gamma-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine 8:440–51
   PubMed Web of Science ®Google Scholar
• Duvoix A, Blasius R, Delhalle S, et al. (2005). Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223:181–90
   PubMed Web of Science ®Google Scholar
• Fischer HC, Chan WCW. (2007). Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565–71
   PubMed Web of Science ®Google Scholar
• Fryer RA, Galustian C, Dalgleish AG. (2009). Recent advances and developments in treatment strategies against pancreatic cancer. Curr Clin Pharmacol 4:102–12
   PubMedGoogle Scholar
• Grainger DW. (2009). Nanotoxicity assessment: all small talk? Adv Drug Deliv Rev 61:419–21
   PubMed Web of Science ®Google Scholar
• Gupta NK, Dixit VK. (2011). Bioavailability enhancement of curcumin by complexation with phosphatidyl choline. J Pharm Sci 100:1987–95
   PubMed Web of Science ®Google Scholar
• Keller KA, Banks C. (2006). Toxicological testing handbook principles, applications, and data interpretation. In: Jacobson-Kram D, Keller KA, eds. M.g.t.s. New York: Informa Healthcare USA, 499
   Google Scholar
• Koziara JM, Oh JJ, Akers WS, et al. (2005). Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm Res 22:1821–8
   PubMed Web of Science ®Google Scholar
• Li Y, Yang DJ, Chen SL, et al. (2008). Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. Pharm Res 25:563–77
   PubMed Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Gantait A, et al. (2007). Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330:155–63
   PubMed Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Gantait A, et al. (2006). Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J Pharm Pharmacol 58:1227–33
   PubMed Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Murugan V, et al. (2009). Exploring the effect of Hesperetin-HSPC complex – a novel drug delivery system on the in vitro release, therapeutic efficacy and pharmacokinetics. AAPS PharmSciTech 10:943–50
   PubMed Web of Science ®Google Scholar
• Mayer A, Vadon M, Rinner B, et al. (2009). The role of nanoparticle size in hemocompatibility. Toxicology 258:139–47
   PubMed Web of Science ®Google Scholar
• Mazumder A, Raghavan K, Weinstein J, et al. (1995). Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 49:1165–70
   PubMed Web of Science ®Google Scholar
• Mohanty C, Sahoo SK. (2010). The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 31:6597–611
   PubMed Web of Science ®Google Scholar
• Morazzoni P, Montalbetti A, Malandrino S, Pifferi G. (1993). Comparative pharmacokinetics of silipide and silymarin in rats. Eur J Drug Metab Pharmacokinet 18:289–97
   PubMed Web of Science ®Google Scholar
• More AB, Chilgunde SN, Kamble JC, et al. (2009). Polyethylene sebacate: genotoxicity, mutagenicity evaluation and application in periodontal drug delivery system. J Pharm Sci 98:4781–95
   PubMed Web of Science ®Google Scholar
• OECD guidelines for the testing of chemicals, T.g. (1995). Repeated dose 28-day oral toxicity study in rodent. Paris: OECD – Organization for Economic Cooperation and Development
   Google Scholar
• Pan CJ, Tang JJ, Weng YJ, et al. (2006). Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents. J Control Release 116:42–9
   PubMed Web of Science ®Google Scholar
• Peeyush KT, Gireesh G, Jobin M, Paulose CS. (2009). Neuroprotective role of curcumin in the cerebellum of streptozotocin-induced diabetic rats. Life Sci 85:704–10
   PubMed Web of Science ®Google Scholar
• Putman DL, Clarke JJ, Escobar P, et al. (2006). Toxicological testing handbook principles, applications, and data interpretation. In: Jacobson-Kram D, Keller KA, eds. Genetic toxicology. New York: Informa Healthcare USA, Inc, 207–15
   Google Scholar
• Rao KS, Xu Y, Shaw E, Parton JW. (2004). Mutagenicity testing applied for regulation of developing products. Curr Separations 20:141–4
   Google Scholar
• Reddy RC, Vatsala PG, Keshamouni VG, et al. (2005). Curcumin for malaria therapy. Biochem Biophys Res Commun 326:472–4
   PubMed Web of Science ®Google Scholar
• Reuter S, Eifes S, Dicato M, et al. (2008). Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76:1340–51
   PubMed Web of Science ®Google Scholar
• Semalty A, Semalty M, Singh D, et al. (2010). Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J Incl Phenom Macrocycl Chem 67:253–60
   Web of Science ®Google Scholar
• Sharma A, Gupta NK, Dixit VK. (2010). Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid. Drug Deliv 17:587–95
   PubMed Web of Science ®Google Scholar
• Shelma R, Sharma CP. (2011). Development of lauroyl sulfated chitosan for enhancing hemocompatibility of chitosan. Colloids Surf B Biointerfaces 84:561–70
   PubMed Web of Science ®Google Scholar
• Torne S, Darandale S, Vavia P, et al. (2012). Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery. Pharm Dev Technol 18:619–25
   PubMed Web of Science ®Google Scholar
• Yadav VR, Suresh S, Devi K, Yadav S. (2009). Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS PharmSciTech 10:752–62
   PubMed Web of Science ®Google Scholar
• Yanyu X, Yunmei S, Zhipeng C, Qineng P. (2006). The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 307:77–82
   PubMed Web of Science ®Google Scholar